Alex Yuan, MD, PhD

Appointed
2012

Education & Fellowships

Fellowship - Cleveland Clinic
Vitreoretinal Surgery
Cleveland, OH USA
2012

Residency - Jules Stein Eye Institute, University of California School of Medicine
Ophthalmology
Los Angeles, CA USA
2010

Internship - Forest Park Hospital
Transitional Year
St. Louis, MO USA
2005

Medical Education - Washington University School of Medicine
MD/PhD Neurosciences
St. Louis, MO USA
2004

Undergraduate - Cornell University
Ithaca, NY USA
1995

Specialty Interests

Regenerative and stem cell therapy, cell-based therapy, gene and drug delivery

Awards & Honors

• Cole Eye Fellow Teaching Award 2012
• Cole Eye Fellow Research Award 2012
• Heed Fellowship Award 2010
• Nesburn Research Award 2010
• UCLA Excellence in Research Award 2007
• Co-investigator NIH R21 Grant 2007
• Oppenheimer Family Foundation Grant 2007
• William Ellis Vision Research Prize 2004
• Spencer T. and Ann W. Olin Fellowship 2003

See publications for Alex Yuan, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/2/2022, Dr. Yuan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.